16.08.2023 14:18:11

AngioDynamics Rises In Pre-market Following Approval Of Its AngioVac System For Expanded Use

(RTTNews) - Shares of medical technology firm AngioDynamics, Inc. (ANGO) are rising more than 8% in pre-market on Wednesday after the company said on Tuesday that the FDA granted Breakthrough Device designation for its AngioVac System "for use to include the non-surgical removal of vegetation from the right heart."

Under the Breakthrough Device designation, the company will engage with the FDA to achieve this new indication, AngioDynamics said in a statement.

AngioVac is a vacuum-based device for percutaneous removal of undesirable materials from the intravascular system. The device was approved in 2014.

AngioDynamics shares closed at $8.69, up 3.08% on Tuesday. It has traded in the range of $8.06 - $24.29 in the last 1 year.

Analysen zu AngioDynamics Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

AngioDynamics Inc. 8,70 0,58% AngioDynamics Inc.